» Articles » PMID: 38491389

Successful Treatment of Recalcitrant Generalized Granuloma Annulare with the JAK Inhibitor Abrocitinib

Overview
Specialty Dermatology
Date 2024 Mar 16
PMID 38491389
Authors
Affiliations
Soon will be listed here.
Citing Articles

[Clinical variables and management of disseminated granuloma annulare - monocentric retrospective analysis of 33 cases between 2021 and 2023].

Spindler M, Berneburg M, Drexler K, Kurz B, Kogel J, Niebel D Dermatologie (Heidelb). 2024; 76(1):27-33.

PMID: 39692762 PMC: 11711856. DOI: 10.1007/s00105-024-05436-2.


Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis.

Mitroi G, Mitroi G, Ica O, Anghelina F, Ciolofan M, Mitroi M Life (Basel). 2024; 14(9).

PMID: 39337910 PMC: 11432974. DOI: 10.3390/life14091127.